Dysregulation of fatty acid synthesis and glycolysis in non-Hodgkin lymphoma
-
- Aadra P. Bhatt
- Lineberger Comprehensive Cancer Center,
-
- Sarah R. Jacobs
- Lineberger Comprehensive Cancer Center,
-
- Alex J. Freemerman
- Department of Nutrition, Gillings School of Global Public Health, School of Medicine, University of North Carolina, Chapel Hill, NC 27599; and
-
- Liza Makowski
- Lineberger Comprehensive Cancer Center,
-
- Jeffrey C. Rathmell
- Departments of dPharmacology and Cancer Biology and
-
- Dirk P. Dittmer
- Lineberger Comprehensive Cancer Center,
-
- Blossom Damania
- Lineberger Comprehensive Cancer Center,
Description
<jats:p>The metabolic differences between B-NHL and primary human B cells are poorly understood. Among human B-cell non-Hodgkin lymphomas (B-NHL), primary effusion lymphoma (PEL) is a unique subset that is linked to infection with Kaposi's sarcoma-associated herpesvirus (KSHV). We report that the metabolic profiles of primary B cells are significantly different from that of PEL. Compared with primary B cells, both aerobic glycolysis and fatty acid synthesis (FAS) are up-regulated in PEL and other types of nonviral B-NHL. We found that aerobic glycolysis and FAS occur in a PI3K-dependent manner and appear to be interdependent. PEL overexpress the fatty acid synthesizing enzyme, FASN, and both PEL and other B-NHL were much more sensitive to the FAS inhibitor, C75, than primary B cells. Our findings suggest that FASN may be a unique candidate for molecular targeted therapy against PEL and other B-NHL.</jats:p>
Journal
-
- Proceedings of the National Academy of Sciences
-
Proceedings of the National Academy of Sciences 109 (29), 11818-11823, 2012-06-29
Proceedings of the National Academy of Sciences
- Tweet
Details 詳細情報について
-
- CRID
- 1360294646826097152
-
- ISSN
- 10916490
- 00278424
-
- Data Source
-
- Crossref